Carbon nanomaterials sensitize prostate cancer cells to docetaxel and mitomycin C via induction of apoptosis and inhibition of proliferation

Scholarly Works

• Sharon, M.; Dubey, A. P. CNF a Cousin of CNT Is Offering a New Arena for Nanomedicine Studies. Nanotechnology in the Life Sciences; Springer Nature Switzerland, 2025; pp 313–345. doi:10.1007/978-3-031-85122-3_6
• Dad, H.; Hansen, A. Advancements in Research on Non-AR- Signaling Pathways and Targeted Therapies for Castration-Resistant Prostate Cancer. annals of urologic oncology 2024. doi:10.32948/auo.2024.12.25
• Wang, J.; Zhang, X.; Xing, J.; Gao, L.; Lu, H. Nanomedicines in diagnosis and treatment of prostate cancers: an updated review. Frontiers in bioengineering and biotechnology 2024, 12, 1444201. doi:10.3389/fbioe.2024.1444201
• Beheshtizadeh, N.; Amiri, Z.; Tabatabaei, S. Z.; Seraji, A. A.; Gharibshahian, M.; Nadi, A.; Saeinasab, M.; Sefat, F.; Kolahi Azar, H. Boosting antitumor efficacy using docetaxel-loaded nanoplatforms: from cancer therapy to regenerative medicine approaches. Journal of translational medicine 2024, 22, 520. doi:10.1186/s12967-024-05347-9
• Garg, A.; Madamsetty, V. S.; Ashique, S.; Gauttam, V.; Mishra, N. Targeted Nanocarriers-based Approach For Prostate Cancer Therapy. Therapeutic Nanocarriers in Cancer Treatment: Challenges and Future Perspective; BENTHAM SCIENCE PUBLISHERS, 2023; pp 133–162. doi:10.2174/9789815080506123010008
• Ahlawat, P.; Kumar, R.; Kumar, A.; Gupta, P. K. Nano-Drug Carriers for Chemotherapeutic Agents Delivery in Cancer Disease Treatment. Nano Drug Delivery for Cancer Therapy; Springer Nature Singapore, 2023; pp 69–95. doi:10.1007/978-981-99-6940-1_4
• Mamidi, N.; García, R. G.; Martínez, J. D. H.; Briones, C. M.; Martínez Ramos, A. M.; Tamez, M. F. L.; Del Valle, B. G.; Segura, F. J. M. Recent Advances in Designing Fibrous Biomaterials for the Domain of Biomedical, Clinical, and Environmental Applications. ACS biomaterials science & engineering 2022, 8, 3690–3716. doi:10.1021/acsbiomaterials.2c00786
• Calatayud, D. G.; Neophytou, S.; Nicodemou, E.; Giuffrida, S. G.; Ge, H.; Pascu, S. I. Nano-Theranostics for the Sensing, Imaging and Therapy of Prostate Cancers. Frontiers in chemistry 2022, 10, 830133. doi:10.3389/fchem.2022.830133
• Freire, T. M.; Sant’Anna, C.; Yoshihara, N.; Hu, R.; Qu, J.; Alencar, L. M. R.; de Barros, A. O. d. S.; Helal-Neto, E.; Fernandes, L. R.; Simões, R. L.; Barja-Fidalgo, C.; Fechine, P. B. A.; Santos-Oliveira, R. Biomedical Application of Graphitic Carbon Nitrides: Tissue Deposition In Vivo, Induction of Reactive Oxygen Species (ROS) and Cell Viability in Tumor Cells. Nanotechnology 2021, 32, 435301. doi:10.1088/1361-6528/ac1540
• Abdo, G. G.; Zagho, M. M.; Al Moustafa, A.-E.; Khalil, A. A.; Elzatahry, A. A. A comprehensive review summarizing the recent biomedical applications of functionalized carbon nanofibers. Journal of biomedical materials research. Part B, Applied biomaterials 2021, 109, 1893–1908. doi:10.1002/jbm.b.34828
• Garg, A.; Garg, S.; Swarnakar, N. K. Nanoparticles and prostate cancer. Nano Drug Delivery Strategies for the Treatment of Cancers; Elsevier, 2021; pp 275–318. doi:10.1016/b978-0-12-819793-6.00012-6
• Cirillo, G.; Peitzsch, C.; Vittorio, O.; Curcio, M.; Farfalla, A.; Voli, F.; Dubrovska, A.; Iemma, F.; Kavallaris, M.; Hampel, S. When polymers meet carbon nanostructures: expanding horizons in cancer therapy. Future medicinal chemistry 2019, 11, 2205–2231. doi:10.4155/fmc-2018-0540
• Hosnedlova, B.; Kepinska, M.; Fernandez, C.; Peng, Q.; Ruttkay-Nedecky, B.; Milnerowicz, H.; Kizek, R. Carbon Nanomaterials for Targeted Cancer Therapy Drugs: A Critical Review. Chemical record (New York, N.Y.) 2018, 19, 502–522. doi:10.1002/tcr.201800038
• Mortimer, M.; Devarajan, N.; Li, D.; Holden, P. A. Multiwall Carbon Nanotubes Induce More Pronounced Transcriptomic Responses in Pseudomonas aeruginosa PG201 than Graphene, Exfoliated Boron Nitride, or Carbon Black. ACS nano 2018, 12, 2728–2740. doi:10.1021/acsnano.7b08977

Explore citations to this article at